Verano Holdings (VRNO) Other Operating Expenses (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Other Operating Expenses of -$27000.0 for Q1 2026, up 67.86% year-over-year from -$16085.1 in Q1 2025, and up 97.39% quarter-over-quarter from -$1.0 million in Q4 2025.
Verano Holdings (VRNO) Other Operating Expenses (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Other Operating Expenses for 6 consecutive years, with -$27000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 67.86% year-over-year to -$27000.0; the TTM figure through Mar 2026 stood at -$1.9 million (down 82.72% YoY), while the FY2025 annual figure was -$2.0 million, down 78.08% from the prior year.
- Other Operating Expenses grew to -$27000.0 in Q1 2026 per VRNO's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $1.4 million in Q3 2022 and bottomed at -$1.0 million in Q4 2025.
- Historically, Other Operating Expenses has averaged -$272062.5 across 5 years, with a median of -$291000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 16133.33% — and 2024, when it slumped 313.43%.
- Verano Holdings' Other Operating Expenses stood at -$408000.0 in 2022, then sank by 39.22% to -$568000.0 in 2023, then jumped by 38.73% to -$348000.0 in 2024, then slumped by 197.13% to -$1.0 million in 2025, then soared by 97.39% to -$27000.0 in 2026.
- Business Quant data shows VRNO's Other Operating Expenses at -$27000.0 in Q1 2026, -$1.0 million in Q4 2025, and -$620000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Verano Holdings | 438.82 Mn | 353.62 Mn | 99.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,000.00 |
| Mar 31, 2026 | -27,000.00 |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | -620,000.00 |
| Jun 30, 2025 | -212,000.00 |
| Mar 31, 2025 | -84,000.00 |
| Dec 31, 2024 | -348,000.00 |
| Sep 30, 2024 | -604,000.00 |
| Mar 31, 2024 | -143,000.00 |
| Dec 31, 2023 | -568,000.00 |
| Sep 30, 2023 | -234,000.00 |
| Jun 30, 2023 | -388,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | -408,000.00 |
| Sep 30, 2022 | 1.44 Mn |
| Jun 30, 2022 | -203,000.00 |
| Mar 31, 2022 | -990,000.00 |
| Dec 31, 2021 | -647,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -429,000.00 |